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The purpose of this review was to describe contemporary screening methodologies and pro-
cesses for determining the substance abuse status of perinatal women using recent literary 
works. It also outlines potential innovations to improve the screening process and subsequent 
treatment of the aforementioned. The study was undertaken as part of the Kuitinmäki project 
in Laurea University of Applied Sciences. This study sought to answer the research question; 
What is entailed in the screening of substance abuse among perinatal women by nurses?  
 
A literature review was the research methodology used for this study and the literature 
search was mainly sourced from articles, journals, books and reports retrieved with the aid of 
electronic databases such as EBSCO (CINAHL), EBSCO (Academic Search Elite) and Pubmed.  
The literature search was facilitated through the use of specified keywords as guiding param-
eters. Data selection from the literature search was based on significance to the research 
task and thereafter, selected data (literary sources) was analysed using an inductive content 
analysis approach to further streamline and perfect the findings.  
 
The findings suggest that a comprehensive assessment  is the acceptable way for nurses to 
detect and draw up a comprehensive care plan for substance abusing perinatal women.  The 
screening process can be further improved by incorporating a dual pronged approach to 
screening perinatal women for substance abuse. This should include the conventional screen-
ing techniques (e.g. questionnaires) and clinical testing methods such as the use of bi-
omarkers.  
 
Nurses and other health care practitioners are also expected to familiarize themselves with 
the appropriate screening methods and tools, by keeping in mind the limitations or innacura-
cies of the different screening tools.  
 
Certain recommendations for health interventions such as for the nurses to create a con-
duisive environment for the screening process and by applying the philosophy of harm reduc-
tion which supports and encourages even the smallest improvements,could significantly im-
prove the screening process and the results.The findings of this study also denote a paucity of 
literature works and research done to fully assess the situation concerning the screening of 
substance abuse among perinatal women and suggests that more research should be carried 
out in this particular field, to incorporate new solutions so as to enhance the operations of 
nurses and other health care practitioners to enable them provide quality holistic care to-
peinatal women and their families.  
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Introduction 
 
 
Pregnancy provides a window of opportunity for the screening of substance abuse by nurses 
and other health care professionals. Screening can be defined as the process of evaluating 
and determining the presence of a particular problem. It often is the initial contact between 
a woman and the treatment system, and the client forms her first impression of treatment 
during screening and intake.  
 
How screening is conducted can be as important as the actual information gathered, as it sets 
the tone of treatment and begins the relationship between the client and the nurse. So it is 
imperative to update nurses’ knowledge while outlining the role they play in the screening 
process. 
 
The main idea behind substance abuse screening of perinatal women is to identify those par-
ticular women who have, or are developing substance abuse problems so as to prevent or lim-
it damages to themselves or their babies. In this way, health professionals can establish 
whether these perinatal women need further assessment and consequent treatment. The es-
sence of assessment is to put together all the necessary information required for a treatment 
plan that meets the individual needs of each perinatal abuser. 
 
Screening of substance abuse among perinatal women involves asking carefully crafted ques-
tions, in order to determine whether an in depth evaluation for a disorder or particular prob-
lem is needed. Based strictly on gender, fewer women can be identified as having a substance 
abuse problem as compared to their male counterparts, yet women experience and exhibit 
more significant health problems following substance abuse within a shorter period of time 
than men (United Nations Office on Drugs and Crime, 2004).  
 
These days unfortunately and increasingly so, substance abuse is becoming more common 
during pregnancy. For example national prevalence surveys in Canada suggest that about 14% 
of women admitted to using alcohol during their last pregnancy, while 17% confirmed they 
were smoking during pregnancy (Wong, Ordean and Kahan, 2011 p.368). Similarly in the USA, 
it is observed that there is an increase in the incidence of substance abuse among pregnant 
women. More than 50% of the respondents to a National Institute on Drug Abuse Household 
Survey aged between 18 to 35 years, admitted to alcohol use within the last month of preg-
nancy and about 5% admitted to the use of illicit drugs within the same period. 
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The importance of substance abuse screening in perinatal women cannot be overemphasized 
given the fact that the abuse of substances is more prevalent than previously thought, with 
up to 25% of pregnant women in the USA using illicit drugs. Once substance abuse during 
pregnancy is detected, the nurse and other health practitioners could be facing challenging 
issues such as foetal and maternal complications. Perinatal women often undergo prenatal 
and postpartum checkups and this provides nurses and other health care practitioners a 
unique window of opportunity for the detection and treatment of substance abuse. These 
checkup sessions not only allow for more frequent access to health care for these perinatal 
women, but also increases the motivation of substance abusing perinatal women to adhere to 
a treatment plan. Starting from the uterus, substance abuse exposure negatively impact neo-
nates and can plague them throughout their life time. Although most pregnant women are not 
guilty of substance abuse, combined data from the National survey on drug use and health 
from 2008 to 2009 in the USA, found out that substance abuse is most prevalent among 
younger perinatal women who reported a greater use of licit and illicit substances(United Na-
tions Office on Drugs and Crime, 2004). More work has to be done to fully grasp the situation 
and negative impact of substance abuse on perinatal women and their families which is not 
necessarily easy because of a myriad of factors such as insufficient resources of health ser-
vices, tentativeness of such women to divulge details of their substance abusing lifestyle and 
their fear of stigmatization (United Nations Office on Drugs and Crime, 2004). A comprehen-
sive screening program (tailored for perinatal women) to a large extent can be instrumental 
to curbing or mitigating the incidence of some of these problems. 
 
The Purpose Statement And Research Questions   
 
1.1 Purpose Statement 
 
The primary aim of this review was to showcase updated knowledge in the contemporary 
screening of substance abuse among perinatal women, while exploring the perinatal sub-
stance abuse screening process, the screening methods, their effectiveness or lack thereof 
and recommendations for better substance abuse screening and management results among 
perinatal women. 
 
Following the Cochrane handbook for systematic literature review on the specific ranges for 
identifying purpose statements (http://Cochrane-handbook.org/), this paper was directed 
towards the enhancement of the quality of knowledge of the main topic. 
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1.2  Research Question 
 
What is entailed in the screening of substance abuse among perinatal women by nurses? 
 
Not only might the answers to this question improve our understanding and help promote bet-
ter substance abuse screening techniques, it might also directly improve the management of 
substance abusing pregnant women and offer better chances for the protection of their foe-
tuses.  
 
 
Definition Of Key Concepts 
 
To ensure a proper comprehension of substance abuse as a phenomenon and its consequent 
relation to screening susceptible perinatal women, it is necessary to define the following 
terms.  
 
1.3 Substance Abuse 
 
This refers to “the harmful or hazardous use of psychoactive substances including alcohol and 
illicit drugs” (WHO 17 Feb, 2013). The initiation and subsequent experimentation into the use 
of alcohol and drugs typically happens during adolescence (Johnston, O'Malley, Bachman, & 
Schulenberg, 2013). The use of psychoactive drugs often causes dependency syndrome in per-
inatal women which results in behavioural, psychological and cognitive eccentricity and re-
petitive addiction as the harmful effects. In perinatal women, substance abuse causes prema-
ture births, FAS (Fetal Alcohol Syndrome) in neonates and underweight/deformed babies etc.  
 
1.4 Substance Dependence 
 
A natural corollary to substance abuse is substance dependence. WHO (2013) defines sub-
stance dependence as “A pattern of behavioural, physiological and cognitive symptoms that 
develop due to substance use or abuse, usually indicated by tolerance to the effects of the 
substance and withdrawal symptoms that develop when the use of the substance is terminat-
ed” . Substance dependence may be diagnosed in the perinatal woman who persists in the use 
of a particular substance, despite problems related to its use.  
 
 
 
 
 
9 
 
1.5 Misuse 
 
The misuse of prescription drug is ideally depicted in the scenario whereby the perinatal 
woman consumes and abuses prescription medication that may have been obtained illegal-
ly/legally, with/without the prescription of a medical professional. Normally, benzodiaze-
pines are abused or strong pain medication like OxyContin. Any use of drugs aside the recom-
mended dosage and/or prescriptions by a certified doctor translates to the misuse/abuse of 
the drug. This may include under dosage, over dosage, reduced or prolonged use, too fre-
quent or infrequent use (Taylor, Bailey, Green, & McCully, 2012).  
 
This refers to the diminishing effects after the continued use of the same amount of sub-
stance/drug, or a need for markedly increasing amounts of the substance/drug to achieve the 
desire effects (Wong et al., 2011 p.370). The development of tolerance can be problematic 
even for patients using prescription medication, as it reduces the effectiveness of the drug 
and this can be especially dangerous for drug addicts because they will take increasingly larg-
er doses to get the same effect, potentially leading to an overdose. Although many tolerance 
producing drugs also have addictive potentials, the development of tolerance is not necessari-
ly addiction.  
 
1.6  Addiction/ Addictive Process 
 
Drug addiction refers to the dependence on a prescribed medication or illegal substance. Ad-
diction causes an intense craving for the drug and makes it virtually impossible to control 
drug use/intake despite the harm they may cause. Mostly starting as a casual experiment, 
drug use and eventually addiction may have long lasting consequences leading to physical and 
mental health problems, broken or failed relationships as well as trouble at work, school or 
with the law for these perinatal women (WHO, 2013).The addictive process is a complex yet 
progressive behavioural pattern that involves sociological, psychological, biological and be-
havioural components. The affected person faces a pathological attachment to the substance 
being abused which limits their ability to control or stop the use of the substance (Taylor et 
al., 2012, p. 2).  
 
 
Research  Method 
 
The  Literature Review was the primary research method for this thesis work. The literature 
review is said to be the replica of scientific and transparent processes that aims to minimize 
bias in a research work through exhaustive literature searches of published and unpublished 
studies and by providing an audit trail of the reviewer’s decisions, procedures and conclusions 
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(Tranfield, Denyer, & Smart, 2003, 207-222). Literature reviews have been found to be a fun-
damental component to improving the daily practice of nursing and other health care disci-
plines primarily because of a reliance on a rigorous and systematic evidence based approach 
which is officially termed as Evidence Based Nursing (EBN) (Aveyard, 2010). For a novice re-
searcher embarking on a research work, Aveyard (2010) recommends the formulation of a re-
search question, strategic and explicit presentation of results as well as a comprehensive dis-
cussion of the results or findings. Aveyard (2010), places particular emphasis on the need for 
a systematic order of doing things in the research as well as sticking to an empirical process 
in order to come out with valid results capable of use in an evidence based practice. Hol-
loway & Wheeler (2009) states that the primary aim of a literature review is to communicate 
to readers already corroborated knowledge on a topic, the strengths and/or limitations of this 
knowledge, as well as contemporize readers on relevant present day research on that topic 
which may include differing opinions from previous research results with regards to the topic 
of concern.  
 
This method of researching was chosen for this study, to assist in pinpointing present day in-
formation on the thesis topic; the vital concepts and theories of the subject area; research 
methodologies which had been utilized previously and also to seek to clarify enigmas in this 
subject area.  
 
1.7 Data Collection 
 
The process of collecting data for this thesis as well as its final synthesis revolved around a 
literature search, screening of literature, data extraction and data analysis.  
 
1.7.1 Literature Search 
 
Literature search is a systematic method of data collection that involves the identification 
and examination of relevant research reports, published papers and books among others (Ave-
yard, 2010). To reemphasize, in the literature search for this thesis, and in order to capture 
the quintessential aspects of the topic and research questions, there was a need for the ad-
herence to a systematic approach. The first step for the literature search was the identifica-
tion of relevant literature sources such as journals, articles and research reports that were 
related to the “screening of substance abuse among perinatal women”. Electronic databases 
and internet search engines proved to be viable sources of literature and also noteworthy, 
was the use of Laurea University of Applied Sciences' library in the quest to come up with 
credible literature works. Electronic databases used in the literature search included: EBSCO 
(CINAHL), EBSCO (Academic search elite), Elsevier Science Direct, Ovid (Medline), Medic, 
Pubmed, Sage, Helka and Google Scholar. 
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Electronic data-
bases 
Possible 
Relevant 
sources 
Rejected 
Sources 
Sources 
not in Eng-
lish 
Incomplete 
Sources 
Broken/ Non-
Functioning 
Sources 
EBSCO (CI-
NAHL) 
 
            X 
    
EBSCO (Aca-
demic Search 
Elite) 
 
            X 
    
Elsevier  
Science Direct 
 
            X 
    
Medic             X     
Ovid (Medline)             X     
Pubmed             X     
Sage                          X    
Helka              X            X   
Google Scholar              X                           X             X 
 
Table 1. Summary of the electronic databases utilized 
 
In the above table, a depiction is made of electronic sources which were considered and 
those sources which were later rejected for one reason or another are shown by the (X) mark. 
To enhance the accuracy of the search process, a combination of keywords were adopted to 
create a search strategy in what is considered to be the Boolean Search Method so as to facili-
tate the location of relevant literature works to the thesis topic. So for instance, a combina-
tions of keywords such as (”Substance Abuse" And "Screening Perinatal women") were utilized.  
Another example of this search method is the use of the keywords combination ("Substance 
Abuse" AND "Screening Perinatal Women" AND "Health Interventions"). This method of litera-
ture search helped to retrieve the most relevant materials regarding screening of substance 
abuse among perinatal women. The table below gives a further depiction of the above pro-
cess. Again in situations whereby articles found on databases were incomplete, Google was 
used to retrieve the complete article. The table also shows the number of hits obtained using 
the different combinations of keywords. 
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Search 
Word(s) 
EBSCO 
(CI-
NAHL) 
EBSCO 
(Academ-
ic Search 
Elite) 
Else-
vier 
Science 
Direct 
Ovid 
(Med-
line) 
Pub-
med 
Sag
e 
Hel-
ka 
Google 
Schol-
ar 
“Substance 
Ause” and 
“Screening in 
Perinatal 
Women” 
 
 
    119 
 
 
  2369 
 
 
  3710 
 
 
     149 
 
 
    677 
 
 
 504 
 
 
  1 
 
 
     159 
“Substance 
Abuse” or 
“Drug Abuse” 
 
   34579 
 
   214455 
 
 165649 
 
   62054 
 
364841 
 
  0 
 
540 
 
  17600 
“Substance 
Abuse” or 
“Drug Abuse” 
and “Screen-
ing in Perina-
tal women” 
 
 
 
   29573 
 
 
 
   15424 
 
 
 
    3241 
 
 
 
     85 
 
 
 
    704 
 
 
 
 0 
 
 
 
  0 
 
 
 
    211 
“Substance 
Abuse Screen-
ing in Perina-
tal Women” 
AND “Nursing 
Interven-
tions” 
 
 
 
     24 
 
 
 
     675 
 
 
 
    958 
 
 
 
        3 
 
 
 
      104 
 
 
 
 0 
 
 
 
  0 
 
 
 
       4 
 
Table 2. Summary of literature search results  
 
1.7.2  Literature Screening 
 
Screening of data retrieved from the literature search was done to decide which literature 
sources could be included and which had to be excluded. Criteria for this classification can be 
seen below and the basis for this classification process was made on concepts deemed to be 
an integral part of using the literature review research methodology. 
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Table 3. Inclusion and Exclusion Criteria 
 
Literature works were screened in two stages during the literature search. Combinations of 
some keywords searches resulted in hits in the excess of tens of thousands of articles. For 
instance, in the situation whereby the keywords "Substance Abuse" OR "Drug Abuse" were used 
thousands of hits of articles came up. After trying several combinations of keywords in the 
search, these keyword combinations "Substance Abuse" AND ”Screening Perinatal women" & 
"Substance Abuse" AND " Screening Perinatal Women" AND "Health Interventions" proved to be 
the most useful. Consequently, the number of hits from the aforementioned searches was 
more concise and tailored to suit integral concepts of the research topic and questions. These 
searches produced over 100 potential articles. These 100 or so articles were further scruti-
nized using their titles and abstracts to get 10 articles which for the most part fulfilled the 
conditions of the inclusion criteria and was congruent to the purpose statement and research 
questions. These 10 articles were saved in Nelli and printed out for further reading and scru-
tiny. Some exceptions were made for articles older than 10 years provided they contained 
relevant information and had been cited by present day literature works/sources.  
 
1.8 Data Extraction 
 
The different data extracted were primarily from the 10 selected articles. For a particular 
data to be extracted, it meant that the article it was extracted from met the inclusion crite-
ria first and foremost, and this data was relevant to the purpose statement and research 
questions. The selected 10 articles from where the data was collected are listed in the Ap-
pendices using categorization(see appendix 4) such as: 
  
 Author & Year of publication  
 Database source  
                         INCLUSION CRITERIA                   EXCLUSION CRITERIA 
Sources Not more than 10 years old (2002-
2012) 
Sources Older than 10 years (2001 and below) 
Sources in English Sources not in English 
Empirical Research Work Speculative Research 
Related to our Key Concepts Unrelated Materials with regards to our Key 
Concepts 
Full Text materials Incomplete or Abstract Materials 
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 Purpose of Research work  
 Research Methodology  
 Central Findings  
 Relevance to this paper 
 
1.8.1 Data Analysis 
 
To expedite the analysis process of findings from the final literature materials, an Inductive 
Content Analysis procedure was employed and utilized. This technique primarily helps in an 
objective, systematic and qualitative description of data retrieved and compiled from various 
literary sources (Aveyard, 2010). For this reason, it is vital to have a full grasp and under-
standing of the selected literature materials to enable one to successfully identify similar 
themes and categorize these themes in groups relevant to one's purpose statement and at 
the same time fulfill the requirements posed by the research questions of the thesis (Hol-
loway & Wheeler, 2009). 
 
 
 
 
 
 
 
 
 
 
Figure 1. Data analysis 
 
The selected 10 articles were read thoroughly several times with special attention given to 
the focal aspect of the purpose statement and research questions. Relevant information to 
the research topic and question were coded using letter and number combinations such as 'A1' 
& 'B2'. Colours were sometimes also used in this sorting process. Descriptions and short notes 
were made in the printed out articles and these were used to create the themes of the thesis. 
The descriptions provided a concise summary of each article and its relevance and connection 
to the other articles. This was fundamental to the aggregation process since similar extracted 
expressions were then grouped together and then given a befitting classification/group name.  
A further synthesis of this new group of extracted expressions was done using the procedure 
described above in order to yield a more definitive and final major category of themes rele-
vant to the thesis topic and research questions. This last synthesis of data was to ensure a 
 
Sorting of 
Data 
Aggregating 
data to yield 
similar 
themes 
Further 
synthesis of 
Data 
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final clarification of each particular phenomenon and its specific category of relevance. Final 
names for major themes depict a commonality of content among its various composites. 
 
Three main classification themes were eventually created; Comprehensive Assessment/ 
Screening, Limitations to substance abuse Screening in Perinatal women and Recommenda-
tions and Health Interventions for  Perinatal substance abuse. The main aim of the qualitative 
analysis of data is to interprete the accumulated data or information so as to arrive at a logi-
cal conclusion (Holloway & Wheeler 2009). To give an example of the analysis process for this 
thesis, the sub-theme of “Substance abuse Risk Factors in perinatal women” was created 
when a group of extractions containing phrases indicative of the various aspects of “History of 
Family member/Partner substance abuse”, “Lack of Family Involment” and “History of having 
other psychological problems” were put together. 
 
Using the same approach. These similar sub-themes were then brought together to form the 
first main theme “Comprehensive Assessment/ Screening”. A similar process was followed to 
arrive at the second and last themes consecutively; “Limitations to substance abuse Screening 
in Perinatal women” and “Recommendations and Health Interventions for  Perinatal sub-
stance abuse”. The figure below depicts the data analysis process. 
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Extracted Data           Sub-Themes               Main Theme 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
History of Family member/Partner sub-
stance abuse, Lack of Family Involment, 
History of having other psychological 
problems 
Recommended routine screening, Recom-
mended periodic screening of pregnant wom-
en, Recommendations for a more flexible 
screening approach, Screening of STD’s and 
HIV if there is history, Screening and treat-
ment of perinatal depression 
Substance abuse legislation, Fear of puni-
tive measures, Fear of stigmatization, 
Fear of loosing child custody, Cultural sen-
sitivity, Linguistic barriers 
 
Screening questionnaires (T-Ace, TWEAK, 
CAGE, SASSI-3), Biomarkers ( EtG, Ets, 
PEth, FAEEs), Nurses’ Screening Skills, In-
dicators for Testing, Nursing Intervention, 
The Philosophy of Harm Reduction 
Unreliable screening questionnaires, Inef-
fective drinking risk identification , False 
negative results for urine and meconium, 
False positive results for hair test  
Establishment of good rapport between staff 
and client, The philosophy of harm reduc-
tion, Training of staff in screening and inter-
view techniques, Substance abuse advisory 
services, Multidisciplinary team approach, 
Informed consent of clients, Importance of 
addressing substance abuse during pregnan-
cy 
 
Comprehensive 
Assessment/ Screening 
Limitations to substance 
abuse Screening in Peri-
natal women 
Recommendations and 
 Health Interventions for  
Perinatal substance 
abuse  
Substance abuse 
Risk Factors in 
perinatal women 
Screening 
Recomme-
ndations for Per-
inatal women 
Socio-Cultural 
Limitations to 
substance abuse 
screening in peri-
natal women 
Limitations to 
Substance Abuse 
Testing Tools 
Universal Screen-
ing of Substance 
Abuse in perinatal 
women 
Health Inter-
ventions for 
substance 
abuse manage-
ment 
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Figure 2. Detailed data analysis 
 
 
Findings 
 
1.9 Comprehensive Assessment/ Screening 
 
The goal of substance abuse screening is to identify women who have or are developing alco-
hol or drug-related problems. Screening Tools as a methodology coupled with a background 
check of the patient's medical history, are deemed to be the most effective ways to verify the 
susceptibility of perinatal women to substance abuse (Bearer et al., 2003). The selection of 
the tools may be based on various factors, including cost and administration time, but the 
decision to use an interview versus a self-administered screening tool should also be based 
upon the comfort level of the counselor or healthcare professional (Thornberry et al. 2002). If 
the healthcare staff communicates discomfort, women may become wary of disclosing their 
full use of substances.  
 
Assessment or screening of the patient is one of the critical elements of effective treatment, 
and it is the first stage of the treatment process.  
 
A comprehensive assessment or screening process uses systematic and extensive procedures 
that determine and evaluate the severity of the substance abuse problem, obtains infor-
mation about cofactors, and assist in developing treatment and follow up plans. Also, an em-
ployment of a comprehensive assessment or screening process by the nurse will translate to 
not only screening for substance abuse per se, but also probing into related problems areas of 
the patient (McLellan & Dembo, 1992) as cited by (Lucenko, Malow, SanchezMartinez, Jen-
nings , & Dévieux, 2003), which may include:  
 
 Overall medical status and problems of the perinatal woman (including general 
health conditions as well as virulent diseases like HIV, tuberculosis and sexually 
transmitted diseases.  
 Psychological status and possible psychiatric disorders.  
 Social functioning; family and peer relations.  
 Educational and work behavioural record.  
 Criminal/delinquent behaviours.  
 Legal problems.  
 Socioeconomic status and problems if present.  
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Results from the comprehensive screening/assessment process should be documented to facil-
itate clinical case supervision. This information will form the basis of a treatment plan. This 
plan must consider the unique constellation of problems and other factors that have been 
identified for each perinatal woman. The plan will propose a course of action that attempts 
to address the unique needs of each perinatal woman. Implementation of the plan will in-
volve referrals to the relevant treatment programs as well as incorporate regular checkups to 
monitor progress. The treatment plan can take a single modality approach or incorporate an 
integrated treatment approach (McLellan & Dembo, 1992) as cited by (Lucenko et al., 2003). 
Lucenko et al. (2003) say that there are three steps in a comprehensive screening process; 
information gathering through interviews (questionnaire format) or laboratory works is con-
sidered to be the first and foremost in these steps. 
 
Screening for substance use disorders is conducted by an interview or by giving a short writ-
ten questionnaire. It often is the initial contact between a woman and the treatment system, 
and the client forms her first impression of treatment during screening and intake. There are 
several risk factors associated with the susceptibility of substance abuse among pregnant 
women and nurses or other health care professionals need to pay more attention in the 
screening of perinatal women who present some of these risk factors (Mayo Clinic, Oct. 2011).  
 
1.9.1 Risk Factors for substance Abuse in Perinatal Women 
 
There are some risk factors associated with the susceptibility of substance abuse among 
pregnant women. These risk factors may include: Having a family history of addiction, pre-
senting other psychological problems, lacking family support or involvement. Nurses and oth-
er health care professionals need to pay more attention in the screening of perinatal women 
who present some of these risk factors (Mayo Clinic, Oct. 2011). In this section we sought to 
throw more light on these risk factors which often but not always predispose perinatal wom-
en to substance abuse.  
 
1.9.1.1 Family/Partner History of Addiction 
 
Drug addiction is more common in some families and likely involves the effects of many 
genes. If the perinatal woman has a blood relative, such as a parent, sibling or even a part-
ner, with alcohol or drug problems, she is at a greater risk of developing a drug addiction.  
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1.9.1.2 Having Other Psychological Problems 
 
Having  another psychological problem, such as depression, attention-deficit/hyperactivity 
disorder or post-traumatic stress disorder, increases the chances for the woman to become 
dependent on drugs. 
 
1.9.1.3 Lack of Family Involvement 
 
A lack of attachment with parents and other siblings may increase the risk of addiction, as 
can a lack of partner supervision.This results in the fact that the woman may have to deal 
with issues of loneliness, depression and anxiety alone. Even the disintergration of family 
such as by death or divorce may increases the likelihood of substance abuse (Mokdad AH, 
Marks JS, Stroup DF, Gerberding JL, 2004) 
 
1.9.2 Universal Screening 
 
Universal screening ensures that the nurse is provided the opportunity to discuss the risks of 
illicit drugs, tobacco, alcohol and other substance abuse problems with perinatal women on a 
routine basis. "Educated guessing" which may rely on the nurse's attitudes and biases can be 
overcome through structured or comprehensive screening which is included in the care of 
every perinatal woman. The practice of universal screening increases the likelihood of identi-
fying substance users and allows for the earliest possible intervention or referral to special-
ized treatment. Additional screening and education of every client enhances public awareness 
of the risks of substance use/abuse during pregnancy and may prevent use/abuse in future 
pregnancies (Taylor et al., 2012).  
 
1.9.2.1 Substance Abuse Screening Tools for Pregnant Women 
 
Screening Tools as a term alludes to an array of different things, it can refer to clinical meth-
ods such as blood tests or urine toxicology tests or to noninvasive methodologies for ascer-
taining the presence of substance abuse in perinatal women such as routine answering of 
structured questionnaires on each perinatal checkup visit to the doctor (Virginia Department 
Of Behavioral Health And Development Services, 2011).  
 
Most substance abuse screening instruments are designed to identify problematic use rather 
than just use; however, if a woman is pregnant, any substance use is problematic.  Screening 
Tools as a methodology coupled with a background check of the patient' s medical history, are 
deemed to be the most effective way to verify the susceptibility of perinatal women to sub-
stance abuse (Bearer et al., 2003). Again, assessment or screening of the patient is one of the 
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critical elements of effective treatment, and it is the first stage of the treatment process. 
Interview based or self-administered screening questionnaire tools are an effective way to 
determine risk or allow for self-reporting since they are considered as routine in perinatal 
care provision. According to the American College of Obstetricians and Gynaecologists (2011), 
brief questionnaires have demonstrated effectiveness in screening for alcohol and drug use 
during pregnancy; some of these tools take 5 minutes or less to go through.  
 
The purpose of the screening should be to begin an open discussion about alcohol and drug 
use especially when screening is interview based or self-administered questionnaires. The 
commonplace practice is to have a mandatory question answer session on each maternal visit 
to the doctor's office. This is carried out regardless of whether there is a suspicion or not of 
the likelihood to abuse substances in the perinatal woman. Most interview screening tools are 
chosen for their brevity, validity, specificity, and sensitivity in detecting alcohol and drug 
problems and they cater to different substance abuse problems. For instance TACE question-
aire caters to alcohol abuse without considering drug abuse. On the other hand, 4 P's Plus is 
an interview tool which covers both alcohol and drug abuse screening.  
 
It is also worthy to note that clinical methods exist which are used postnatally to detect sub-
stance abuse. These categories of screening tools are relevant because they help to detect 
and subsequently deter recurrent substance abuse in the patient, should she get pregnant 
again. Interview techniques and screening instruments may be designed to attempt to get 
alcohol or drugs involved persons to reveal information about their substance abuse. These 
self-administered reports can be helpful in determining whether there is a need for further 
scrutiny of the patient and intervention. The are quite a number of different substance abuse 
screening tools, but the most commonly used and recommended screening tools/ question-
naires for perinatal women are: T-Ace, TWEAK, CAGE and SASSI-3 and 4Ps (See appendices 1 
and 3). 
 
1.9.2.2 Clinical Screening Tools / Biomarkers 
 
Atypical to the conventional screening tools such as questionnaires or interviews, clinical 
screening tools employ invasive methods to test for the presence of substance abuse among 
perinatal women. Clinical screening methods can be used both prenatally and postnatally for 
the aforementioned purpose (Bakhireva & Savage, 2011). In recent times, biomarkers as clini-
cal screening tools are consider avant-garde in this area of screening for substance abuse. 
Biomarkers as a term can be defined as basically the science of detecting traces elements of 
illicit/licit substances using body secretions of the patient. In the case of perinatal women, 
these elements may evident in the course of the pregnancy or after the birth of the neonatal.  
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An ideal biomarker for detecting alcohol use among pregnant women for instance, should 
have the following attributes: 
 The capacity to detect low to moderate levels of drinking over extended periods of 
time after the last drinking episode. 
 A high probability of accurately detecting drinking that occurred during pregnancy 
(i.e., high sensitivity). 
 A low rate of false positive test results (i.e. high specificity).  
 
In addition, important technical considerations for a biomarker testing include: 
 A biological sample easily obtained by a minimally invasive and clinically acceptable. 
 A procedure that requires little or no sample preparation.  
 A simple, relatively inexpensive analytical procedure that provides rapid results, 
ideally in a point of care setting (Bakhireva & Savage, 2011).  
 
Literature works attest to the significance of biomarkers in screening for substance abuse; in 
certain cases they were proven to be more effective than the conventional screening methods 
(interview based or self-administered questionnaires). Results of a pilot study (Wurst et al. 
2008b) in Sweden, indicated that clinical testing for EtG and FAEEs (trace elements of sub-
stance abuse) can identify more potential alcohol consumers among pregnant women than the 
AUDIT questionnaire alone (Kip et al. 2008). PEth and EtG (biomarker tests) combined, were 
able to identify alcohol consuming patients who scored below the cutoff on an AUDIT ques-
tionnaire interview in an emergency room setting (See Appendix 2). 
 
1.9.2.3 Screening Skills and Demeanor 
 
Screening is a skill, and nurses should be trained in interview techniques as well as ethics to 
ensure a perfection of this skill. Essentially, screening for substance abuse among perinatal 
women should be routinely performed by trained nurses well versed in the knowledge of sub-
stance abuse and pregnancy. This approach tends to reduce subjectivity, discomfort, bias for 
all involved parties (Roberts & Nuru  Jeter, 2010). Ideally, all pregnant women should be 
screened at every visit or at least once a trimester. As patient nurse trust grows, the likeli-
hood of the perinatal woman to disclose substance abuse also increases. When the patient 
discloses use of substances, it is vital the nurse is aware that screening tools identify risk and 
are not diagnostic. Consequently, nurses should be trained and know how to respond in such 
situations. They should be able to discuss the risks associated with abuse, the benefits of 
stopping substance abuse, and resources for available further evaluation/intervention. How 
screening is handled, impacts the perinatal woman’s use of perinatal care services later. If 
women fear adverse consequences or judgmental attitudes, they often delay or avoid perina-
tal care services (Roberts & Nuru Jeter, 2010). Also of relevance, is the need to include in-
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quiries into substance abuse problems with regards to the perinatal woman's family; this is to 
ensure a holistic approach in creating a treatment plan and is ethically benevolent.  
 
In summary, the screening process should be carried out in an environment of respect where-
by the general tone of the nurse doing the screening is non-judgmental and supportive. It is 
vital that patient confidentiality is protected and the interview process is culturally relevant. 
The nurse in charge of the screening procedure (be it interview based/self-administered 
questionnaire or invasive clinical procedural) should make sure to discuss the benefits of 
treatment and offer to provide the perinatal woman with a referral to a local substance abuse 
treatment Centre. Again, the patient's consent should be sort for prior to any screening pro-
cedure. This will presuppose that clear and honest communication has taken place between 
the nurse and the perinatal woman (Kellogg, Rose, Harms & Watson, 2010). In the situation 
the woman refuses to give consent, the nurse should proceed to enquire if the patient would 
prefer to take information leaflets for later reading. After this, the nurse in charge of the 
interview can proceed to schedule the next meeting or perinatal visit. The nurse should con-
tinue to maintain interest in the client's progress and support her efforts in changing (Massey 
et al., 2012).  
 
1.9.2.4 Indicators for Testing 
 
According to Roberts & Nuru Jeter (2010), nurses must be aware of telltale signs which may 
depict the presence of substance abuse in perinatal women. These can include frequent ab-
senteeism from routine perinatal checkups; alcohol odor and also the medical history can 
provide information of a substance abuse past. Below is a table of the common signs and be-
havioural patterns associated with substance abuse: 
 
 
Table 4. Symptoms of Substance Abuse (Taylor et al. 2012) 
 
 
 
 
BEHAVIOUR PATTERNS PHYSICAL SIGNS 
Sedation Dillated pupil 
Euphoria Tremors 
Aggressive Hair Loss 
Paranoia Hallucinations 
Depression Increased Body Temperature 
Psychosis Increased Pulse and Blood Pressure 
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1.9.2.5 Nursing Intervention in the Screening Process 
 
It is the responsibility of every hospital or practice to ensure that all perinatal women are 
screened for substance use or vulnerability to abuse. Physicians, nurses, and others involved 
in perinatal care play an important role in the reduction of substance use during pregnancy. 
For perinatal women who require help for substance use, a multi-team approach is recom-
mended; this normally involves the primary health provider, clinic nurse, social worker, pub-
lic health nurse, chemical dependency treatment provider, and the client herself (Kellogg et 
al. 2010). Education of this health care team is vital to enable proper client screening; team 
members must be taught on when and how to screen, how to assist the woman who admits 
abuse of illicit substances or the one who denies the abuse of substances (Kellogg et al., 
2010).  
 
The role of the nurse is precursory to the input from other team members in the multi-team 
when catering to substance abusing perinatal women since it is the nurse who conducts the 
actual screening. It goes without saying that, it is vital the nurse plays this role well since this 
is the first step in drawing up a treatment plan to provide care for such women. Nurses should 
as a result be properly equipped and knowledgeable about situations whereby the perinatal 
woman denies or admits to substance abuse.  
 
1.10  Limitations to Substance abuse Testing  in Perinatal Women 
 
There are a number of limitations in the substance abuse testing. Both the testing tools and 
the samples being tested could be the cause of the innacurate results. Moreso, there are also 
legal and socio-cultural aspects that may limit authenticity of the clients answers (Taylor et 
al. 2009). Some important aspects to consider are that: 
 
 Negative results do not rule out substance use, a positive test does not necessarily tell how 
much of a drug is used and a positive test does not identify user characteristics such as inter-
mittent use, chronic use, or addiction. 
 
1.10.1 Socio-Cultural Limitations to substance abuse screening in perinatal women 
 
• The most common limitation as the world is getting more intercultural is the aspect 
of cultural sensitivity or linguistic barriers 
• A woman who knows she will be tested may delay access to prenatal care because she 
fears potential repercussions. Such repercussions may be legal costing the costudy of 
her child, or even social whereby she could be stigmatized by her community, friends 
or relatives. 
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• False positive results can be devastating for a drug-free client. 
• Women may avoid detection by abstaining for 1–3 days prior to testing, substituting 
urine samples, or increasing oral beverage intake such as water, just before the test-
ing in order to dilute the urine (Wong et al. 2011). 
 
1.10.2 Limitations to Substance Abuse Testing Tools 
 
• Blood tests usually only identify those patients with long term use in whom secondary 
symptoms have occurred, e.g., liver function tests. 
• Urine toxicology has no value in identifying or minimizing the teratogenic effects that 
occur  early in pregnancy. 
• Alcohol, which is the most widely abused substance and has the greatest impact on 
the fetus,     is the hardest to detect due to its short half-life. 
• Hair analysis could have a false-positive result because of passive exposure to smoke 
drug in the environment (Wong et al. 2011). 
 
1.11 Health Interventions for substance abuse management 
 
In this section we outline some of  the roles of the nurse or other health care providers as 
well as their philosophy in the management of substance abuse. 
 
1.11.1 The Philosophy of Harm Reduction 
 
Nurses typically apply the philosophy of harm reduction in the screening and management of 
perinatal women. Harm reduction is a public health philosophy and intervention that seeks to 
reduce the harms associated with drug use and ineffective drug policies (Rebecca Tiger, 
2010). Dixon, Kurtz, & Chin (2008) explains that nurses should as much as possible make sure 
that susceptible or abusing perinatal women are educated and informed about the availability 
and benefits of referral and health services. Again, Niccols et al. (2012) advocate for an 
integrated treatment approach involving various disciplines in caring for perinatal abusers. 
Components of this philosophy includethe encouragement of abstinence or redeuction of use, 
safe use, counseling and treatment of withdrawal symptoms or pharmacotherapy (Wong et al. 
2011)  
 
Abiding by this philosophy, the nurse may make a number of recommendations if complete 
cessation by the perinatal woman is not immidiately possible or feasible. Examples of such 
recommendations could include: 
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• The nurse can encourage the woman to keep track of substance use.  
• She can discuss the benefits of reducing dosage and frequency of use with perinatal 
abusers.  
• The nurse can recommend the patient reduce her use by one-half each day; if this is not 
possible, any decrease in use is beneficial.  
• The nurse can also recommend that the patient intersperse use with periods of abstinence.  
• The nurse can also encourage a safer route of drug administration and help the patient 
explore substitutes for the particular substance being abused. For instance the use of 
methadone for opiate dependence.  
• The nurse can also encourage the patient to avoid drug using friends.  
 
The nurse could also make potential referrals (Integrated care provision)  to the perinatal 
woman such as:  
• Childbirth preparation class  
• Public assistance/medical assistance/food stamps  
•Nutrition Program 
•Support groups  
• Education and career building support  
• Safe and sober housing access  
• Legal services  
• Child Protective services  
• Adoption counseling  
• Pediatric follow-ups care for infant  
• Mental health services  
• Domestic violence counseling and services ( Taylor et al. 2009). 
 
1.11.2 Screening Recommendations for Perinatal women 
 
• Pregnant women as well as women of childbearing age should be screened periodical-
ly for tobacco, alcohol, prescription and illicit drug use. 
• If the testing of substance abuse is clinically indicated, urine drug screening is the 
most recommended method. 
• Health care workers are advised to develop a flexible approach towards the care of 
women with substance abuse problems. How screenings and assessments are conduct-
ed is as important as the information gathered. Screening and assessment are often 
the initial contact between a woman and the treatment system (Wong et al 2011). 
They can either help build a trusting relationship or create a deterrent to engaging in 
further services. 
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• Legal requirements or policies with respect to the drug testing of newborns, may vary 
by jurisdiction and it is imperative that nurses and other health care professionals to 
be acclimatized to the regulations in their region 
• Self-administered tools may be more likely to elicit honest answers; this is especially 
true regarding questions related to drug and alcohol use.  
• Face-to-face screening interviews have not always been successful in detecting alco-
hol and drug use in women, especially if the counselor is uncomfortable with the 
questions.  
• Substance abuse screening and assessment tools, in general, are not as sensitive in 
identifying women as having substance abuse problems.  
• Selection of screening and assessment instruments should be examined to determine 
if they were developed using female populations. If not, counselors need to explore 
whether or not there are other instruments that may be more suitable to address spe-
cific evaluation needs. 
 
 
Discussion 
 
In recent times, although the overall rates of substance use are lower among pregnant women 
compared to nonpregnant women, the rate of illicit drug use for pregnant women aged 15 to 
17 (16%) doesn't significantly differ from the rate for nonpregnant women in this age range 
(13%) (Substance Abuse and Mental Health Services Administration [SAMHSA], 2011a). Alcohol 
is the most ubiquitous teratogen whilst tobacco use is the most commonplace addiction 
among young perinatal women (Porter & Kaplan, 2011).  
 
The innocuous acceptance of alcohol and tobacco in Western society enables young women 
to form habits long before they become pregnant making it much harder to quit those habits 
once they realize they are pregnant. It is in light of this trend prevalent among young perina-
tal women who engage in the 'social abuse' of alcohol and other drugs, that a compelling 
need arises to take a thorough look at screening processes already in place for ascertaining 
the potential and/or incidence of substance abuse in perinatal women. This is vital since de-
tection of the substance abuse problem by comprehensive screening/assessment is the first 
step in treating it thoroughly.  
 
On site screening and provision of accessible nursing service to substance abusing perinatal 
women is important since these women are statistically known to have fewer resources (edu-
cation, employment, income) than men, have care of dependent children and are comorbid 
at the beginning of screening and treatment (United Nations Office on Drugs and Crime, 
2004).  
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The issue of the education of these women cannot be downplayed or overemphasized, (Mas-
sey et al. (2012), advocate that the maternal identity (self-esteem) of these women should be 
affirmed regularly in order to attain and maintain a level of abstinence since to a large de-
gree most women really do want healthy babies. Women also of child bearing age should be 
educated on regular basis about the dangers of alcohol and drugs exposure to the health of 
the unborn baby; which lingers throughout the breastfeeding period and also into early child-
hood.  
 
A noteworthy feature this literature review makes evident is the paucity of technological in-
novations in the routine screening process of perinatal women in recent years. As a result of 
this, it is crucial to increasingly inculcate technological advancements or innovations from 
other disciplines to this aspect of nursing so as to improve the screening process. In the USA, 
the National Aeronautics and Space Administration (NASA) has developed a technological pro-
ject known as VIPER (Visual Identification of Pupillary Eye Responses) in conjunction with the 
Corrections & Prisons Department and this project has come out with an instrument called 
optical funduscope. This instrument can measure involuntary eye movements associated with 
drug use impairment and is deemed to be a great tool to screen substance abuse exposure 
according to Jackson (1992) cited in (Nissen & Kraft, 2007).  
  
An innovation worthy of consideration is the Telemetered Drug Use Detection System.  
This system basically detects drug use by analysing perspiration using a wrist band innovation 
worn by the suspected or vulnerable abuser. When the device detects drug use, it forwards 
the information to a central control station. This technology combines position identification, 
microcommunications, chemical and biological processes as well as signalling to facilitate the 
screening process. It is a noninvasive detection method of drug use (Jackson, 1992) as cited 
by (Nissen & Kraft, 2007). It will be very beneficial if these technological innovations can be 
enhanced in a way that makes them more user friendly in screening perinatal abusers since 
these technological innovations according to (Jackson, 1992) were developed primarily for the 
Corrections and Prisons Services (cited by Nissen & Kraft, 2007).  
 
Dixon et al. (2008) postulates that the manipulation of the perinatal atmosphere through 
child skills training and parent education, can help reduce adverse conditions normally linked 
with substance abuse exposure in the perinatal period. Integrated or a comprehensive ap-
proach to tackle the issue of substance abuse among perinatal women is crucial to ending in-
tergenerational cycles of addiction in certain neighbourhoods. For instance, through the use 
of onsite stations, nursing services can be conveniently delivered to perinatal abusers. This is 
crucial for continuous monitoring and improvement of the lives of perinatal abusers and their 
families (Niccols et al., 2012).  
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1.12 Ethical Considerations 
 
American College of Obstetrics and Gynecology Committee (2008) defines ethics as the philo-
sophical study of morality, moral judgments and moral problems. Ethical issues may arise 
from moral dilemmas; a conflict of social values and ethical principles that support different 
courses of action. Retrieval of data from inanimate sources during the research process obvi-
ously leads to issues which have to be resolved and catered to ethically. The research for this 
thesis was conducted through systematic literature review and for that matter; there was no 
data acquisition from human sources through interviews, questionnaires or observations. 
Since human candidates weren't considered in the data acquisition process, ethical considera-
tions such as privacy/confidentiality and avoidance of harm are rendered null and void. On 
the other hand, it is vital to mention that attention was given to ethical considerations such 
as:  
 
• Accurate reporting  
• Proper referencing  
• Veracity and authenticity of sources  
 
The research of this thesis was ethically in following a systematic empirical method of col-
lecting and analyzing data. Accurate reporting of articles was done to avoid misrepresenta-
tions or the incidence of bias. Proper referencing was also incorporated to avoid plagiarism. 
The main objective of this thesis work is to describe nurses’ role in the screening process, 
depict current trends in screening of perinatal abusers and finally make recommendations of 
potential improvements that can be made. 
 
1.13  Trustworthiness 
 
Graneheim & Lundman (2004) purport that legitimate research, is research comprising of 
trustworthy findings which essentially alludes to an efficacious or effective research method-
ology. The use of the literature review method as the research methodology of this thesis in 
essence, makes for a 'legitimate research' since this methodology seeks to employ a scientific 
or empirical approach of data retrieval, aggregation and the final synthesis of this data. This 
approach ultimately seeks to decrease bias because of its systematic nature (Tranfield et al., 
2003). 
 
In qualitative research, noteworthy to the research work are the four aspects of trustworthi-
ness. These are noted to be the issues of credibility, transferability, dependability, and con-
formability as relevant to the final research work.  
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Credibility can be defined as an assessment as to whether or not research findings depict a 
true picture or interpretation of the original data. Transferability is the extent to which the 
research findings are pertinent; thus fitting and relevant to different settings or scenarios 
beyond the research/project work. Dependability can also be defined as the evaluation of the 
quality of the integrated processes of data collection, its analysis and further synthesis to en-
gender or generate the research findings. Conformability finally, determines how accurately 
the research findings are corroborated by information or data sources retrieved (Agostinho, 
2004).  
 
This paper incorporates the above ethical principles in its research work; this is readily evi-
dent by the categorical outlining of the process used for data search (retrieval), data sorting, 
and data synthesis to yield common themes and to ensure proper interpretation. The data 
used in this thesis was collected through a literature review mostly from medical/health 
journals and articles. The original data from these sources is deemed viable having faced rig-
orous academic scrutiny prior to publication.  
 
To ensure conformability, the reference system in this thesis follows the Laurea's thesis 
guidelines. Citations are made to all articles, journals and other information sources used to 
avoid plagiarism and to give credit where necessary. The use of in-text referencing and a final 
list of references are implemented as proof of conformability in this thesis.  
 
The dependability and credibility of this thesis is evident primarily because a frame work was 
employed in the literature search and data analysis to increase accuracy and decrease bias in 
the data. For instance in the literature search, this framework employed an exclusion and 
inclusion criteria to get the most relevant data sources in answering the research question. 
This search strategy as a result, came up with 10 articles relevant to identifying the screening 
of substance abuse among perinatal women. To ensure continuity, the review methodology 
was followed stringently by having relevant discussions with the thesis supervisors and also 
between the authors of the thesis (peer review). Evidence gaps have also been identified, 
with the potential that existing knowledge could be extended in a way that deepens under-
standing and creates awareness as stated in the recommendations for further studies.  
 
1.14  Credibility 
 
Credibility of this thesis is apparent whereby data is empirically analyzed to engender com-
mon themes. Using an Inductive Content Analysis process, relevant information to the re-
search topic and questions were coded using a combination of letters and numbers such as 'A1' 
& 'B2'. Colours were sometimes also used to facilitate the creation of common themes (sum-
maries) for further group analysis. According to Graneheim & Lundman (2004), data interpre-
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tation requires an adequate volume of information analysed to solicit relevant conclusion and 
this thesis does this by applying the aforementioned methodology. 
 
1.15 Limitations 
 
A prime limitation of writing this thesis work included issues/instances of technical difficul-
ties with search engines, restricted articles accessible only by membership, unobtainable full 
text articles, language barriers in deciphering foreign language based articles (in Finnish) and 
also situations whereby databases were temporarily unavailable.  
 
Another major limitation is the fact that the articles used for this paper where not only fo-
cused on nurses, but mostly covered the interventions of the multidisciplinary health team 
including gynaecologists and obstetricianans.  
 
Moreso, the articles were from different countries such the USA, Canada, Australia, UK, Fin-
land etc, where the health care procedures, duties and responsibility of nurses vary. 
The paucity of literary works and research/innovations pertaining to screening of substance 
abuse among perinatal women seems to be a worldwide phenomenon and Finland is no excep-
tion according to (Tanhua, Virtanen, Knuuti, Leppo, & Kotovirta, 2011), as the structural 
framework for engaging drug abuse is mainly male oriented. 
 
 
 Conclussion 
 
A risk factor for poor behavioural and developmental outcomes among children is perinatal 
exposure to substance use (Coles & Black, 2006) and the total lifetime costs of caring for a 
substance abuse exposed child have been estimated to be between $750,000 and $1.4 million 
(Kalotra, 2002); it is in light of the aforementioned statistics that this review sought to em-
phasize the significance of the screening process catering to perinatal women as the first step 
to contain and remedy this problem.   
  
As of now, a comprehensive assessment  is the only way for nurses to detect and draw up a 
comprehensive care plan for substance abusing perinatal women. The detection process in-
volves interviews or self-administered questionaires, while considering the risk factors such 
as: Having a family history of addiction, presenting other psychological problems, lacking 
family support or involvement. Nurses and other health care professionals need to pay more 
attention in the screening of perinatal women who present these risk factors (Mayo Clinic, 
Oct. 2011). 
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The care plan has to take into consideration the screening tools and methods, as well as the 
resources available to the client. It is also the responsibility of the nurse to create a con-
duisive environment for the screening interview to take place and to update his or her 
knowledge of screening methods and screening tools innovations. 
 
Information search for literature materials on screening of substance abuse among perinatal 
women is sparse and arduous to come by. It is therefore necessary that better methods of 
obtaining maternal risk information/ susceptibility to drugs are developed so as to make rele-
vant progress in this field of nursing science. The fact also stands that perinatal women are 
apprehensive in disclosing potentially stigmatizing information about their substance abuse 
habits, which may hamper the screening process. To counter this problem, Bakhireva and 
Savage (2011) proposed a two pronged approach/solution whereby the normal screening in-
terviews (self/nurse administered) are mandatorily complemented with the use of biomarkers 
in the screening process in order to increase the rate of detection of substance abuse among 
perinatal women. The use of clinical biomarkers will also help eliminate inconsistencies evi-
dent in conventional self-reported data and other screening techniques.  
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Appendices  
 
Appendix 1.  Cage Questionaire for alcohol abuse Screening 
  
 
 
 
 
 
 
 
 
 
 
 
 
                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CAGE 
C- Have you ever felt you ought to cut down on your drinking or drug use? 
A- Have people annoyed you by criticizing your drinking or drug use? 
G- Have you ever felt bad or guilty about your drinking or drug use? 
E- Eye-opener: Have you ever had a drink or drug first thing in the morning to 
steady your nerves or get rid of a hangover? 
The CAGE can identify alcohol problems over the lifetime. Two positive responses are 
considered a positive test and indicate further assessment is warranted. 
National Institute on Alcohol Abuse and Alcoholism cited by (Taylor et al. 2012) 
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Appendix 2.  Promminent Biomarkers and their Reliability 
 
BIOMARKERS SUBSTANCE TESTED 
FOR 
BIOLOGICAL SAMPLE 
SOURCE 
RELIABILITY/ SENSI-
TIVITY 
Ethyl Glucuronide  
(EtG) 
 
Alcohol Urine (Mother’s) High 
Ethyl sulfate (EtS) Alcohol Urine (Mother’s) Medium 
Fatty Acid Ethyl  
Esters (FAEEs) 
 
Alcohol, cocain, Opi-
ates etc 
Meconium  
( 1st stool of baby), 
Hair  
samples  
from new baby. 
 
High 
Phosphatidylethanol  
(PEth) 
 
Alcohol Dried blood  
spot (DBS)  
from heel of  
new born  
baby 
 
Medium 
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Appendix 3.  The 4P’s Questionnaire for alcohol and drug screening 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4PS 
Have you ever used drugs or alcohol during this Pregnancy? 
Have you had a problem with drugs or alcohol in the Past? 
Does your Partner have a problem with drugs or alcohol? 
Do you consider one of your Parents to be an addict or alcoholic? 
This screening device is often used as a way to begin a discussion about drug or 
alcohol use. Any woman who answers yes to one or more questions should be re-
ferred for further assessment. 
Ewing H. Medical Director, Born Free Project (2010), Contra Costa County, Mar-
tinez, CA 94553. cited by (Taylor et al. 2012). 
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Appendix 4. Data extraction form 
Author and 
year of pub-
lication 
Database 
source 
Purpose of 
research 
work 
Research 
methodology 
Central find-
ings 
Relevance to this 
paper 
Bar-Oz, B., 
Klein, J., 
Karaskov, 
T., & Koren, 
G. (2003) 
Ebsco 
(Cinahl) 
Compares 
the use of 
meconium 
and neonatal 
hair analysis 
for detection 
of gestation-
al exposure 
to drugs  
Randomized 
control trial 
Both meconium 
andneonatal 
hairare effec-
tive biological 
markers of in 
utero illicit 
drug exposure. 
The importance 
of biomarkers  
testing in the 
screening for sub-
stance abuse 
Wong, S., 
MD,Ordean, 
A., & Meldon 
Kahan, M. 
(2011) 
Pubmed Systematic 
review and 
observation 
of  screening 
techniques 
and man-
agement of 
problematic  
substance 
use during 
pregnancy 
and lacta-
tion. 
Qualitative 
studies & Ran-
domized con-
trol trial (RCT) 
Evidence based 
recomendations 
for screening 
and manage-
ment of prob-
lematic sub-
stance use dur-
ing pregnancy 
and lactation 
Examples of 
screening ques-
tionnaires and 
intervention 
methods to sub-
stance abuse 
Chang, G., 
Fisher, D.L, 
Hornstein, 
M.D.,Jones, 
A.J., &Orav, 
E.J. (2010) 
Ebsco (Ac-
ademic) 
Compares 
the T-ACE 
screening 
tool andthe 
use of medi-
cal record 
for identifi-
cation of 
risky drinking 
Quantitative 
studies 
Need for more 
work to be 
done to devel-
op more sensi-
tive biomarkers 
Improvements in 
biomarkers and 
screening  of sub-
stance abuse 
Bakhireva, 
L.N., & Sav-
age, D.D. 
Elsevier 
Science 
Direc 
Developing 
more sensi-
tive and spe-
Qualitative 
studies 
Need for more 
work to be 
done to devel-
Improvements in 
biomarkers and 
screening  of sub-
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(2011) cific bi-
omarker sys-
tems 
op more sensi-
tive biomarkers 
stance abuse 
Varjonen, 
V., Tanhua, 
H.,Forsell, 
M.,Perälä, 
R. (2012) 
Google 
Scholar 
Report on 
the drug sit-
uation  in 
Finland 
Epidemiological 
survey 
Drug use and 
drug-related 
problems have 
remained fairly 
stable in Fin-
land over the 
past years 
Recommendations 
for improving 
treatment system 
for perinatal 
abusers in Finland 
Taylor, P 
Bailey, D., 
Green, S.R., 
&McCully, C 
( 2012) 
SAGE Assessment 
of substance 
abuse during 
pregnancy 
Systematic re-
view& Evi-
dence Based 
Practice 
Screening 
techniques and 
tools in recent 
times 
Demeanor and 
ethicsof nurses 
during the 
screening process 
Tanhua, 
H.,Virtanen, 
A.,Knuuti, 
U.,Leppo 
A.,Kotovirta, 
E. (2011) 
(Ovid) 
Medline 
Yearly up-
date  
on drug 
abuse  
trends in  
Finland 
 
Qualitative  
studies  
 
Dynamics of 
drug  
abuse in recent  
times 
 
Legislation and  
statutory provi-
sion  
for perinatal 
women  
abusers of  
substances 
 
Massey S.H.,  
Neiderhiser, 
J.  
M., Shaw, D.  
S., Leve, L. 
D., 
Ganiban, J. 
M., 
& Reiss, D  
(2012). 
 
Google 
Scolar 
To test cor-
relation be-
tween self-
concept and 
substance 
abuse among 
perinatal 
women 
RCT Enhancing ma-
ternal identity 
as a provider 
for the fetus 
during preg-
nancy, along 
with treatment 
of depression, 
may improve 
motivation to 
stop substance 
use 
Nursing demeanor 
and intervention 
of substance 
abuse in perinatal 
women 
Kellogg, A.,  
Rose, C.H.,  
Harms, R.H.,  
Watson, 
Pubmed Evaluate 
trends 
and preva-
lence 
Retrospective  
cohort study 
 
Chronic narcot-
ic use 
during preg-
nancy is  
Substance abuse  
trends and  their  
corollary effect 
on  
 40 
  
 
 
W.J.  
(2010).  
 
of chronic  
prescription  
narcotic use  
during  
pregnancy 
and  
the 
subsequent 
neonatal  
outcomes 
   
 
increasing in  
prevalence 
 
perinatal women 
and 
neonates 
 
Niccols, A.,  
Milligan, K.,  
Smith, A.,  
Sword, W.,  
Thabane, L., 
& 
Henderson, 
J.  
(2012 
 
Pubmed Systematic  
review to  
examine the  
effectiveness 
of 
integrated  
programs for  
mothers with  
substance  
abuse issues 
 
Systematic Re-
view 
parenting skills 
and 
general mater-
nal  
health of peri-
natal  
women im-
proved  
after undergo-
ing  
treatment in  
integrated 
program  
centres 
 
The importance 
of a  
multi-team ap-
proach 
in treating peri-
natal  
substance abusing  
women 
 
